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ABSTRACT  
Background: Intestinal coccidia are group of protozoa which parasitize the epithelial cells of the intestinal tract of their hosts. 
Most infections usually produce mild, self-limiting infections in man, but they now constitute a serious public health problem, 
especially in developing countries with inadequate sanitary conditions coupled with widespread HIV/AIDS infection.               
Objective: To determine the Prevalence of intestinal coccidian parasites burden in HIV/AIDS patients on antiretroviral therapy in 
HIV Centers in Mubi, Nigeria  
Materials and Methods: This was a hospital-based cross-sectional study in which stool specimens from  HIV-positive patients on 
ART were examined for the presence ofoocysts of intestinal coccidian parasitesusing Modified Acid Fast Stain technique. In 
addition, patients’ blood samples were analyzed for CD4 count by flow cytometry and packed cell volume (PCV) through 
microhaematocrit centrifugation. 
Results A total of 305 specimens examined, 236(77.4%) were positive for Cryptosporidium parvum, Isospora belli and 
Microsporidium species. Patients within the age group of 21 – 30 were the most infected. Generally, the duration of ART 
influenced the prevalence of the intestinal coccidian parasites. There was a highly significant association between the CD4 count 
and prevalence coccidian parasites (p ˂ 0.05). There was a significant negative correlation (r = -0.95) between the duration of the 
ART and the prevalence of coccidian presence.  
Conclusion: Routine screening of HIV-positive patients for intestinal parasites is advocated as standard operative procedure (SOP) 
before antiretroviral therapy (ART) is given. Construction of public health facilities, toilets and boreholes as well as public 
enlightenment campaign is recommended for more effective management of these patients.  
Keywords: intestinal coccidian parasites, antiretroviral therapy, Mubi 
 
LA PREVALENCE DES COCCIDIES INTESTINALES CHEZ LES PATIENTS ATTEINTS DE VIH/SIDA SOUS 
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Résumé 
Contexte: Les coccidies intestinales sont un groupe de protozoaires qui parasitent les cellules épithéliales du tube digestif de leurs 
hôtes. La plupart des infections humaines sont  d'habitude  peu sévères et autolimitées, mais elles constituent de nos jours un 
véritable problème de santé publique, particulièrement dans des pays en voie de développement où les conditions sanitaires sont 




Objectif: Déterminer la fréquence de coccidies intestinales chezles patients atteints de VIH/SIDA sous traitement antirétroviral 
dans les Centres de contrôle de VIH de Mubi au Nigeria. 
Matérielset Méthodes: Il s’agissait d’une étude transversale dans laquelle les spécimens de selles des patients séropositifs au VIH 
et sous traitement antirétroviralétaient examinés en vue d’en dépister là  la présence d’oocystes de coccidies intestinales grâce à la 
technique de de coloration acido-résistante modifiée. De plus, les prélèvements de sang des patients  étaient analysés pour en 
déterminer le taux de CD4 et le taux demicro-hématocrite par les techniques de flux cytométrique et de centrifugation 
respectivement. 
Résultats: Untotal de 305 spécimens ont été examinés, 236 (77.4 %) étaient positifs pour le Cryptosporidiumparvum,le Isospora belli 
et les espèces de Microsporidie. Les patients dans la tranche d'âge de 21 – 30 ans  étaient les plus infectés. Généralement, la durée 
du traitement antirétroviralinfluençait la fréquence des coccidies intestinales. Il y avait une association fortement significative 
entre le taux de CD4 et les infections(p< 0.05). Il existait une corrélation négative significative (r =-0.95) entre la durée detraitement 
antirétroviralet la fréquence de coccidies intestinales. 
Conclusion: Le dépistage de routine des patients séropositifs pour des parasites intestinaux est préconisé dans la procédure 
opératoire standard avant toute administration de thérapie antirétrovirale. La construction d'installations de santé publique, des 
toilettes et des puits de forage ainsi que des campagnes d'éducationsanitaire sontfortement recommandées en vue d’une prise en 
charge effectivedes patients atteints de VIH. 
Mots-clés : coccidies intestinales, thérapie antirétrovirale, Mubi 
INTRODUCTION 
Gastrointestinal tract (GIT) infections constitute a 
serious public health problem in developing countries 
with inadequate sanitary conditions coupled with 
widespread HIV/AIDS infection. Many different types 
of intestinal parasites infect man, provoking a wide 
range of symptoms that are generally associated with 
gastrointestinal tract disorders and are dependent on 
demographic, socio-economic, physiological and 
immunological factors [1]. With the progressive 
development of AIDS, especially once 
CD4+Tlymphocyte counts have fallen below 200 
cells/µl, patients often become co-infected by bacteria, 
parasites or viruses [2]. Gastrointestinal tract parasitic 
infections often present as diarrhea and significant 
disease has been recorded in 50-96% of cases with 90% 
prevalence rate reported in Africa [3].Infective causes 
of chronic diarrhea may satisfactorily be managed 
because with the exception of cryptosporidiosis and 
HIV-related enteropathy, good response to treatment 
can be expected [4], but all etiologic agents are not 
easily diagnosed in Africa on routine basis because of 
limited diagnostic facilities and trained personnel [5].  
Following HIV infection, the virus replicates rapidly in 
lytic cycles inside resident tissue macrophages and 
CD4 + T lymphocytes. This results in depletion of these 
vital immune cells, rendering the individual 
susceptible to opportunistic pathogens, a host of which 
include intestinal protozoa, resulting in the frequently 
observed diarrhea in this group of persons [6].The 
incidence and prevalence of infection with a particular 
enteric parasite in HIV/AIDS patients is likely to 
depend upon the endemicity of that particular parasite 
in the community [7].Several parasites have been 
implicated as major contributors to morbidity in HIV-
infected persons living in developing countries, and 
the parasites frequently encountered include mostly 
intestinal coccidia such as: Cryptosporidium spp., 
Isospora belli andMicrosporidia spp [8]. Most of these 
infections in man are zoonotic (having the potential to 
infect animals or arise from animals). In 
immunocompetent individuals, they usually produce 
mild, self-limiting infections [9].  
Cryptosporidium parvum is the species responsible for 
human infections and is now widely recognized as a 
cause of acute gastro-enteritis, particularly in children 
and other immunosuppressed persons such as AIDS 
patients [10]. The infection produces a persistent, 
watery, offensive diarrheic stool, often accompanied by 
abdominal pain, nausea, vomiting and anorexia. In 
immunocompetent persons, symptoms are usually 
short lived (1 to 2 weeks). The small intestine is the site 
most commonly affected. In immunocompromised 
individuals, especially in HIV patients, 
Cryptosporidiosis can be life threatening. As many as 
10% of AIDS patients pass oocysts of C. parvum in their 
stools[11].Isospora belli has a cosmopolitan distribution; 
occurring especially in warm regions of the world 
infecting both humans and animals [12].It is endemic 
in Africa, Asia and South America. Infection with I. 
bellimanifest as darrhea with abdominal cramp which 
can last for weeks and result in fat malabsorption and 
weight loss. In immunocompromised individuals, 
infants and children, infection ranges from self-limiting 
enteritis to severe diarrhea illness resembling that of 
cryptosporidiosis [13]. Cyclospora cayetanensishas also 
been described in association with diarrhea illness but 
the infection usually results in a disease with non-
specific symptoms [14].Microsporidia species are known 
as opportunistic pathogens in humans with Acquired 




beenimplicatedinconditions ranging from enteritis to 
keratoconjunctivitis [15].The most common 
Microsporidia found in patients with AIDS are 
Enterocytozoon bieneusi, Encephalitozoon intestinalis and 
Encephalitozoon hellem.Patients with these infections 
tend out to be severely immuno-deficient with a CD4+ 
T cell count less than 100 x 106/L [16]. In addition, 
cases of microsporidiosis have been reported in 
immunocompromised persons not infected with HIV 
and in immunocompetent individuals. The clinical 
manifestations of microsporidiosis are very diverse, 
varying according to the causal species with diarrhea 
being the most common [16]. 
Since the prevalence of parasites associated with 
gastroenteritis is dependent of their geographical 
distribution and socio-economic factors surrounding a 
given community, laboratory investigations are 
required to determine prevalence in each population in 
order to provide an effective planning and 
management policy.Human immunodeficiency virus 
(HIV) and parasites have long been of public health 
concern and have drawn global attention. However, 
although much work have been done on the 
prevalence of parasites in HIV patients, at the moment 
there is scarcity of information on the prevalence of 
intestinal coccidia among HIV positive patients in 
Mubi HIV centers of Adamawa State, Nigeria. The 
availability of such data will be an enormous 
contribution to the implementation of regulatory 
policies on the management of HIV/AIDS patients, 
hence this study was conducted. 
MATERIALS AND METHODS 
Study area  
Adamawa state is located in the North Eastern part of 
Nigeria. It lies between latitude 7˚ and 11˚ north of the 
equator and longitude 11˚ and 14˚ east of the 
Greenwich Meridian. It is divided into 21 Local 
government areas [17].The growth of Mubi town is 
traced to the agricultural, administrative, and 
commercial functions it performs. The hospitals in 
which this study was carried out arethe three HIV 
specialized centers of the Mubi General Hospital which 
geo-politically covers Mubi North, Mubi South, and 
Michika Local Governments.The Hospitals care for the 
people living with HIV and also receives patients from 
other parts of the country due to their consistent 
supply of reagents for CD4+ counts for HIV infected 
patients. 
Sample collection 
The study was cross-sectional hospital based study 
carried out from June to October 2013. Male and 
female HIV/AIDS patients visiting the hospital for 
treatment or routine follow-up were provided with 
information on the purpose/objectives of the study 
andits possible benefits. They were however explained 
that it was not an obligation for them to participate in 
the research and neither was it a pre-requisite to 
accessing routine medical or other social services 
publicly available. The effective study participants 
(ESP) were those whoconsented and provided stool 
samples for laboratory investigation and their blood 
samples were taken for CD4+ T cell determination.  
Freshly voided stool samples were collected into clean 
wide mouth specimen containers from volunteer 
participants. A portion of the stool was preserved in 
10% formalin in a proportion of 10g of stool in 3 mL of 
formalin.  Five mL of venous blood were collected into 
coated EDTA tubes for CD4+ T cell counts and packed 
cell volume (PCV).The ESP were grouped based on 
their levels of immune suppression thus: Based on the 
CD4+ T cell counts, the participants were categorized 
by their immune status according to the 1993 Revised 
Classification System for the HIV Infection by CD4 T-
cell categories [18].Samples were numbered 
progressively for identification and these laboratory 
numbers ensured individual 
confidentiality.Participants were not billed for the tests 
and the physicians were provided with the findings for 
necessary action. The samples collected for the study 
as resolved with the participants were solely used for 
the defined purpose. The ethical clearance was 
approved by the Ethical Committee of the Hospital 
prior to sample collection. 
Modified Ziehl Neelson Stain 
Detection of intestinal coccidian parasitesoocysts in the 
concentrated stool was done using the modified cold 
Ziehl Neelsen staining technique. A concentrated 
smear of the stool was made on a clean grease-free 
slide and fixed in methanol for 3 minutes. The slide 
was immersed in cold Carbol fuchsin and stained for 
15 minutes. It was then thoroughly rinsed in tap water 




minutes. After rinsing again in tap water, the slide was 
counterstained with 0.4% malachite green for 30 
seconds. The slide was then air-dried and observed 
under the compound light microscope using 40x 
objective lens for the presence of Cryptosporidium 
oocysts, which was confirmed under the oil-immersion 
objectives as small pink to red spherules on pale green 
background. 
Determination of CD4+ T cell count 
Blood samples collected from the same patients who 
provided stool samples were analyzed for CD4+ T 
lymphocyte cell estimation using flow cytometry. 
Briefly, 20 µl of CD4 PE antibody was placed into a 
Partec test tube and 20µl of well-mixed whole EDTA 
blood was added, mixed gently and incubated in the 
dark for 15 minutes at room temperature. The mixture 
was agitated during incubation every 5 minutes. 800 µl 
of CD4 buffer was added to the mixture of antibody 
and sample and mixed gently. This was then plugged 
to the counter for counting. 
Determination of the Packed Cell Volume (PCV) 
The PCV was estimated by centrifuging a sample of 
well-mixed anticoagulated blood in capillary tubes 
using the microhaematocrit centrifuge. The machine 
was set at 12,000g for 5 minutes which automatically 
attains the correct speed. The PCV was subsequently 
estimated by measuring the height of the red cell 
column and expressing it as a ratio of the height of the 
total blood column. A PCV reader determined this 
ratio [19]. 
Data analysis  
Data got from the processing of sampleswere analyzed 
using SPSS 12.0.The Chi-Square test was used to 
compare proportions at significant level of 0.05. 
RESULTS 
A total of 305 specimens examined, 236(77.4%) were 
positive for Cryptosporidium parvum, Isospora belli and 
Microsporidium species. Table 1 shows the prevalence 
of coccidian parasites in study participants according 
to gender. There was no significant difference in the 
prevalence by gender of participants (P> 0.05). 
 












Cryptosporidium  parvum 
32 (47.0) 95 (40.1) 127(41.6) 
Isospora belli 
23 (33.8) 72 (30.4) 95(31.1) 
Microsporidium species 
2 (2.9) 10 (4.2) 12(3.9) 
Total 
57 (83.8) 177 (74.6) 234(76.7) 
 
 
The Prevalence of coccidian parasites in study 
participants according to age is shown in Table 2. 
Patients within the age group of 21 – 50 were the most 
frequently infected, though there was no significant 

















21—50                             
(n=239) 
>51    (n=36) 
Cryptosporidium  parvum 
10 (33.3) 102(42.7) 15(41.7) 127(41.6) 
Isospora belli 
9 (30.0) 74 (30.9) 12(33.3) 95(31.1) 
Microsporidium species 1 (3.3) 11 (4.6) 0 12(3.9) 
Total 
20 (66.6) 187 (78.2) 27(75.0) 234(76.7) 
 
Table 3 shows the prevalence of intestinal coccidian 
parasite infection according to the duration of ART by 
patients. There was a highly significant association 
between the prevalence of intestinal coccidian parasites 
and to the duration of treatment by patients (P<0.05) 
 




Number (%) of patients having been treated for 
Totaln = 
305 1 yr 
n = 85 
2 yrs 
n = 80 
3 yrs 




n = 30 
6 yrs  
n = 5 
7 yrs 
n = 15 
Cryptosporidium 
parvum 40(47.1) 19(23.8) 31(51.7) 17(56.7) 14(46.7) 1(20.0) 5(33.3) 127(41.6) 
Isospora belli 
27(31.8) 21(26.3) 21(35.0) 8(26.7) 10(33.3) 3(60.0) 5(33.3) 95(31.1) 
Microsporidiumspecies 
7(8.2) 1(1.3) 2(3.3) 0(0) 1(3.3) 0(0) 1(6.7) 12(3.9) 
Total 
74(87.0) 41(51.1) 54(90.0) 25(83.3) 25(83.3) 4(80.0) 11(73.3) 234(76.7) 
 
Table 4 shows the prevalenceof parasites in study 
participants according to CD4 count. There was a 
strong negative correlation (r = -0.95) between the 
duration of the ART and the prevalence of coccidian 
presence and the association between CD4 count of 
patients and the presence of coccidian parasites 
showed a high level of significance (P < 0.05) 
DISCUSSION  
In this study, there was a high prevalence (76.7%)  of 
coccidian parasite infection in the study population 
conducted during . The fact that the study was 
conducted during the wet period could account for this 
unexpected high prevalence; Previous studies in 
Rwanda [20] and Kenya [21]have shown that peaks of 
infection tend to occur in the wet months.  Reports 
from West Africa [22,23] and Zambia [24] have shown 
human infections peak early in the season, perhaps 
because susceptible populations develop immunity 




prevalence can further be explained by the widespread 
of common open toilets, the incidence of random 
defecation, and the occurrence of stormy winds. It has 
been shown by Siobhan et al [25] that the storm water 
runoff during rainy seasons undoubtedly increases 
environmental transport of feces and wet, humid 
conditions favor parasite survival. Also the intensive 
rearing of cattle in the region and the use of ovine 
manure as fertilizer surely goes a long way to enhance 
the epidemiology of parasites. Moreover, the lack of 
hygiene can equally enhance the transmission of these 
parasites.Risk factors for acquisition of parasitic 
infections are the same in both immunocompetent (IC) 
and immunosuppressed (IS) individuals. The immune 
system plays an integral part in modifying the 
establishment of infection, controlling disease once it is 
established, limiting the severity and dissemination of 
the disease, and assisting in clearance or control of the 
parasite. Thus, immunosuppressed hosts are more 
likely to acquire infection after exposure, have more 
severe disease once the infection is established, have 
disseminated infection rather than localized infection, 
and be unable to clear parasites with chronic carriage 
states. These all lead to, and account for, the greater 
morbidity and mortality in these patients. 
In our study, there was no significant difference in the 
prevalence by gender of participants. This finding 
disagrees with the report from Kenya [26]. The authors 
argued that that exposure to Cryptosporidium was 
influenced by gender, age and role in the household. 
Adult women had more daily contact with cattle faeces 
than adult men, and older women had more contact 
than older men. Women took more care of sick people 
and were more at risk from exposure by this route. We 
foundno significant difference in the prevalence of 
infection with coccidian intestinal parasite by age. This 
finding is not in accordance with a report from India 
[27] in which the highest prevalence of these organisms 
was in the group aged 16-45 years and during the rainy 
months. A similar study carried out in Israel [28] 
reported an Age-related infection with Cryptosporidium 
species. Since these infections may be asymptomatic or 
present as a mild self-limited disease, many infected 
peoples do not seek medical aid. Consequently, under-
appreciation and over-appreciation of infection with 
intestinal coccidians may occur depending on the 
diagnostic technique used. Our study population 
comprised HIV-positive patients already on ART: it 
was not the case for the earlier-mentioned reports. That 
is probably the reason for the above disagreements. 
 
TABLE 4: PREVALENCEOF PARASITES IN STUDY PARTICIPANTS ACCORDING TO CD4 COUNT 
 
Parasites 
Number (%) of infected patients with  CD4 count 
Totaln= 305             
<200 
n=30 




Cryptosporidium parvum 14(46.7) 92(45.8) 21(28.4) 127(41.6) 
Isospora belli 11(36.7) 65(32.3) 19(25.7) 95(31.1) 
Microsporidium species 0(0) 8(4.0) 4(5.4) 12(3.9) 
Total 25(83.3) 165(82.1) 44(59.4) 234(76.7) 
 
 
Since the patients involved in this study were all on 
ART, one could have expected a lower parasites load, 
since the treatment is supposed to have boosted their 
immune status. Thus, comparison in this study 
between the parasite load and the immune status of 
patients based on their CD4+ T cell counts according to 
the 1993 Revised Classification System for the HIV 
infection by CD4+ T-cell categories by Castro et al.[18] 
showed that 83.3% of the patients infected with the 
opportunistic coccidians were significantly associated 
with CD4 count below 200. This is in concordance with 




protozoan parasites is dependent on absolute CD4+T 
cell counts, with lower counts being associated with 
more severe disease [29]. 
The present study showed no significant difference in 
the intestinal profiles of study participants using wet 
preparation based on their CD4+T cell counts. On the 
other hand, unlike the non-opportunistic parasites, low 
CD4 count (83.3% with <200 CD4 count) was highly 
significantly associated with the presence of 
coccidians, where there is a decrease in CD4 counts at 
the beginning of treatment and a higher prevalence of 
the parasites. 
The mean PCV of the patients with CD4 count less 
than 200 was significantly lower compared to those 
with CD4 count within 200 and 500, and those with 
CD4 above 500. Though one cannot ascribe the patients 
in this study to be anemic, previous studies have 
shown that  CD4+T cell count of  less than 200cells/µL 
were associated with an increased risk of parasitic 
infection among HIV-infected patients, and co 
infection with Malaria, a risk to anemia [30]. This is 
important as CD4 count of less than 200cells/ µL is 
believed to be associated with disease progression and 
opportunistic infections. This may explain the 
association between CD4 count and parasitic infections 
among HIV patients with anemia. 
CONCLUSION  
The prevalence of Coccidian parasites in HIV/AIDS 
patients attending Mubi HIV centres is relatively 
high.Female patients were more infected with 
commonly identified parasites through wet 
preparation while there was no significant difference 
in infection rates with opportunistic parasites. The age 
range most affected in this study was between 21 to 40 
years, with the peak between 21 to 30 years for the 
opportunistic coccidians.As the duration of treatment 
increased, the parasitic load decreased.There was no 
significant difference in the intestinal profiles of study 
participants using wet preparation while the 
prevalence of patients infected with the opportunistic 
coccidians was highly significantly associated with 
CD4 count.There was no significant difference between 
CD4 count and PCV, though lower PCV was equally 
associated with low CD4 counts. Public health 
measures should continue to emphasize the 
importance of environmental and personal hygiene as 
well as provide and monitor the source and quality of 
drinking water. This is a very important point as the 
community depends a lot on wells as sources of water 
and the prevalent wind storms disseminate the 
pathogens throughout the localities. Stool processing 
should be a routine in HIV/AIDS patients attending 
treatment centers and more training should be given to 
health practitioners and laboratory technicians about 
opportunistic emerging parasites. 
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